Pharmaceutical market of the EAEU countries is a promising market due to the high demand in innovative and effective medical solutions and medicines, a set of government measures aimed at developing the pharmaceutical industry in the territory of the EAEU, health system reform to increase access to modern medical technologies and drugs. In recent years, the EAEU member countries have made a significant progress in the development of the pharmaceutical industry due to the implementation of numerous programs in the EAEU states. For example, in the Russian Federation due to program «PHARMA 2020» production competencies and facilities covering a wide range of medicinal products has been developed. The international pharmaceutical industry made a major contribution to the implementation of this program, invested more than 5 billion euro in this sector, and contributed more than 30 billion in country economy. Currently the program «PHARMA 2030» is being developed. It has the aim of the R&D sector development, export orientation, research competencies. An additional impetus to the development of the regional market as a whole and its national segments is provided by the creation of a single market for EAEU medicines, harmonized with international standards, including ICH and EU, and currently being implemented by member states.
Representatives of industrial associations, pharmaceutical manufactures, developers, regulatory authorities, other stakeholders concerned and representative of the Eurasian Economic Commission (TBC) participate in the session.
Kevin Ali, President of MSD International, shares his vision of the future of healthcare: why vaccination is needed, how to win the race with bacteria, and whether it is possible to invent a universal medicine to fight cancer.
Russias success in the future depends largely on the dynamics of human capital. Health and education are two main human capital issues. Leadership in the global economy will increasingly be determined by the countrys competitiveness in the global markets of educational and medical technologies and services. In this connection, in the industry whose orientation is limited primarily to the detection and treatment of diseases, healthcare should become an integrated interdisciplinary system that can not only more effectively solve medical and social problems, but also be one of the main drivers of the growth of the Russian economy.